Baiyunshan announced on the evening of September 3. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., a holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Ceftazidime for injection has passed the consistent evaluation of the quality and efficacy of generic drugs.

Zhitongcaijing · 09/03/2025 10:17
Baiyunshan announced on the evening of September 3. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., a holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Ceftazidime for injection has passed the consistent evaluation of the quality and efficacy of generic drugs.